NCT04075032View on ClinicalTrials.gov

Pomegranate Consumption by Poly-medicated Metabolic Syndrome Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 10, 2018

Primary Completion Date

July 21, 2019

Study Completion Date

December 31, 2019

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Pomegranate extract

Pomegranate extract consumption (900 mg/day) for 4 weeks

OTHER

Placebo

Placebo (microcrystalline cellulose) consumption (900 mg/day) for 4 weeks

Trial Locations (1)

30100

Spanish National Research Council (CSIC), Murcia

Sponsors
All Listed Sponsors
collaborator

Hospital General Universitario Reina Sofía de Murcia

OTHER

lead

National Research Council, Spain

OTHER_GOV

NCT04075032 - Pomegranate Consumption by Poly-medicated Metabolic Syndrome Patients | Biotech Hunter | Biotech Hunter